Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 1

Conditions

Melanoma 19Neuroblastoma 16Leukemia 15Prostatic Neoplasms 14Lymphoma 12Multiple Myeloma 10Breast Neoplasms 10Lymphoma, Non-Hodgkin 8Leukemia, Myeloid, Acute 8Leukemia, Lymphocytic, Chronic, B-Cell 8Glioblastoma 8Neoplasm Metastasis 6Myelodysplastic Syndromes 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Fallopian Tube Neoplasms 6Neoplasms 5Hodgkin Disease 5Carcinoma, Non-Small-Cell Lung 5Uveal Melanoma 4Recurrence 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Kidney Neoplasms 4Glioma 4Carcinoma, Renal Cell 4Carcinoma, Ovarian Epithelial 4Breast Neoplasms, Male 4Ovarian Neoplasms 3Neoplasms, Plasma Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3

Interventions

Cyclophosphamide 176Rituximab 164fludarabine phosphate 97Peripheral Blood Stem Cell Transplantation 95Filgrastim 73Etoposide 67Radiotherapy 63Mycophenolic Acid 62Whole-Body Irradiation 58Tacrolimus 49Melphalan 49Cyclosporine 49Busulfan 47Lenalidomide 45Antilymphocyte Serum 39Vincristine 37Prednisone 37Cytarabine 37fludarabine 35Methotrexate 33Carmustine 32obinutuzumab 31Doxorubicin 30Bendamustine Hydrochloride 30Methylprednisolone 27ibritumomab tiuxetan 25Cord Blood Stem Cell Transplantation 25sargramostim 24Bortezomib 24Granulocyte Colony-Stimulating Factor 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Lymphoma, Follicular × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT02677155 2021-03-01

Lymvac-2

Oslo University Hospital

Phase 2 Completed
10 enrolled
Lymphoid

Lymphoma, Follicular

NCT00411086 2017-12-05

Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
60 enrolled 9 charts
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT00073931 2015-02-05

Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Fred Hutchinson Cancer Center

Phase 2 Completed
25 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡